Pharma & Healthcare
Global Infertility Drugs Market Research Report 2026
- Mar 14, 26
- ID: 731968
- Pages: 105
- Figures: 109
- Views: 8
This report delivers a comprehensive overview of the global Infertility Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Infertility Drugs. The Infertility Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Infertility Drugs market comprehensively. Regional market sizes by Type, by Application, by Indication, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Infertility Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck
Ferring
MSD
LIVZON
Abbott
Bayer Zydus Pharma
Segment by Type
Gonadotropins
Anti-Estrogens
Other
Segment by Indication
Ovulatory Dysfunction
Luteal Phase Deficiency
Other
Segment by Route of Administration
Oral Formulations
Injectable Formulations
Vaginal or Transdermal Form
Segment by Application
Hospitals
Retail Pharmacy
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Indication, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Infertility Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Infertility Drugs market comprehensively. Regional market sizes by Type, by Application, by Indication, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Infertility Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck
Ferring
MSD
LIVZON
Abbott
Bayer Zydus Pharma
Segment by Type
Gonadotropins
Anti-Estrogens
Other
Segment by Indication
Ovulatory Dysfunction
Luteal Phase Deficiency
Other
Segment by Route of Administration
Oral Formulations
Injectable Formulations
Vaginal or Transdermal Form
Segment by Application
Hospitals
Retail Pharmacy
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Indication, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Infertility Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infertility Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Gonadotropins
1.2.3 Anti-Estrogens
1.2.4 Other
1.3 Market by Indication
1.3.1 Global Infertility Drugs Market Size Growth Rate by Indication: 2021 vs 2025 vs 2032
1.3.2 Ovulatory Dysfunction
1.3.3 Luteal Phase Deficiency
1.3.4 Other
1.4 Market by Route of Administration
1.4.1 Global Infertility Drugs Market Size Growth Rate by Route of Administration: 2021 vs 2025 vs 2032
1.4.2 Oral Formulations
1.4.3 Injectable Formulations
1.4.4 Vaginal or Transdermal Form
1.5 Market by Application
1.5.1 Global Infertility Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Hospitals
1.5.3 Retail Pharmacy
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Infertility Drugs Market Perspective (2021–2032)
2.2 Global Infertility Drugs Growth Trends by Region
2.2.1 Global Infertility Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Infertility Drugs Historic Market Size by Region (2021–2026)
2.2.3 Infertility Drugs Forecasted Market Size by Region (2027–2032)
2.3 Infertility Drugs Market Dynamics
2.3.1 Infertility Drugs Industry Trends
2.3.2 Infertility Drugs Market Drivers
2.3.3 Infertility Drugs Market Challenges
2.3.4 Infertility Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infertility Drugs Players by Revenue
3.1.1 Global Top Infertility Drugs Players by Revenue (2021–2026)
3.1.2 Global Infertility Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top Infertility Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Infertility Drugs Revenue
3.4 Global Infertility Drugs Market Concentration Ratio
3.4.1 Global Infertility Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infertility Drugs Revenue in 2025
3.5 Global Key Players of Infertility Drugs Head Offices and Areas Served
3.6 Global Key Players of Infertility Drugs, Products and Applications
3.7 Global Key Players of Infertility Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Infertility Drugs Breakdown Data by Type
4.1 Global Infertility Drugs Historic Market Size by Type (2021–2026)
4.2 Global Infertility Drugs Forecasted Market Size by Type (2027–2032)
5 Infertility Drugs Breakdown Data by Application
5.1 Global Infertility Drugs Historic Market Size by Application (2021–2026)
5.2 Global Infertility Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Infertility Drugs Market Size (2021–2032)
6.2 North America Infertility Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Infertility Drugs Market Size by Country (2021–2026)
6.4 North America Infertility Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infertility Drugs Market Size (2021–2032)
7.2 Europe Infertility Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Infertility Drugs Market Size by Country (2021–2026)
7.4 Europe Infertility Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Infertility Drugs Market Size (2021–2032)
8.2 Asia-Pacific Infertility Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Infertility Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific Infertility Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Infertility Drugs Market Size (2021–2032)
9.2 Latin America Infertility Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Infertility Drugs Market Size by Country (2021–2026)
9.4 Latin America Infertility Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infertility Drugs Market Size (2021–2032)
10.2 Middle East & Africa Infertility Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Infertility Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa Infertility Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Infertility Drugs Introduction
11.1.4 Merck Revenue in Infertility Drugs Business (2021–2026)
11.1.5 Merck Recent Development
11.2 Ferring
11.2.1 Ferring Company Details
11.2.2 Ferring Business Overview
11.2.3 Ferring Infertility Drugs Introduction
11.2.4 Ferring Revenue in Infertility Drugs Business (2021–2026)
11.2.5 Ferring Recent Development
11.3 MSD
11.3.1 MSD Company Details
11.3.2 MSD Business Overview
11.3.3 MSD Infertility Drugs Introduction
11.3.4 MSD Revenue in Infertility Drugs Business (2021–2026)
11.3.5 MSD Recent Development
11.4 LIVZON
11.4.1 LIVZON Company Details
11.4.2 LIVZON Business Overview
11.4.3 LIVZON Infertility Drugs Introduction
11.4.4 LIVZON Revenue in Infertility Drugs Business (2021–2026)
11.4.5 LIVZON Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Infertility Drugs Introduction
11.5.4 Abbott Revenue in Infertility Drugs Business (2021–2026)
11.5.5 Abbott Recent Development
11.6 Bayer Zydus Pharma
11.6.1 Bayer Zydus Pharma Company Details
11.6.2 Bayer Zydus Pharma Business Overview
11.6.3 Bayer Zydus Pharma Infertility Drugs Introduction
11.6.4 Bayer Zydus Pharma Revenue in Infertility Drugs Business (2021–2026)
11.6.5 Bayer Zydus Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infertility Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Gonadotropins
1.2.3 Anti-Estrogens
1.2.4 Other
1.3 Market by Indication
1.3.1 Global Infertility Drugs Market Size Growth Rate by Indication: 2021 vs 2025 vs 2032
1.3.2 Ovulatory Dysfunction
1.3.3 Luteal Phase Deficiency
1.3.4 Other
1.4 Market by Route of Administration
1.4.1 Global Infertility Drugs Market Size Growth Rate by Route of Administration: 2021 vs 2025 vs 2032
1.4.2 Oral Formulations
1.4.3 Injectable Formulations
1.4.4 Vaginal or Transdermal Form
1.5 Market by Application
1.5.1 Global Infertility Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Hospitals
1.5.3 Retail Pharmacy
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Infertility Drugs Market Perspective (2021–2032)
2.2 Global Infertility Drugs Growth Trends by Region
2.2.1 Global Infertility Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Infertility Drugs Historic Market Size by Region (2021–2026)
2.2.3 Infertility Drugs Forecasted Market Size by Region (2027–2032)
2.3 Infertility Drugs Market Dynamics
2.3.1 Infertility Drugs Industry Trends
2.3.2 Infertility Drugs Market Drivers
2.3.3 Infertility Drugs Market Challenges
2.3.4 Infertility Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infertility Drugs Players by Revenue
3.1.1 Global Top Infertility Drugs Players by Revenue (2021–2026)
3.1.2 Global Infertility Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top Infertility Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Infertility Drugs Revenue
3.4 Global Infertility Drugs Market Concentration Ratio
3.4.1 Global Infertility Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infertility Drugs Revenue in 2025
3.5 Global Key Players of Infertility Drugs Head Offices and Areas Served
3.6 Global Key Players of Infertility Drugs, Products and Applications
3.7 Global Key Players of Infertility Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Infertility Drugs Breakdown Data by Type
4.1 Global Infertility Drugs Historic Market Size by Type (2021–2026)
4.2 Global Infertility Drugs Forecasted Market Size by Type (2027–2032)
5 Infertility Drugs Breakdown Data by Application
5.1 Global Infertility Drugs Historic Market Size by Application (2021–2026)
5.2 Global Infertility Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Infertility Drugs Market Size (2021–2032)
6.2 North America Infertility Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Infertility Drugs Market Size by Country (2021–2026)
6.4 North America Infertility Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infertility Drugs Market Size (2021–2032)
7.2 Europe Infertility Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Infertility Drugs Market Size by Country (2021–2026)
7.4 Europe Infertility Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Infertility Drugs Market Size (2021–2032)
8.2 Asia-Pacific Infertility Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Infertility Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific Infertility Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Infertility Drugs Market Size (2021–2032)
9.2 Latin America Infertility Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Infertility Drugs Market Size by Country (2021–2026)
9.4 Latin America Infertility Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infertility Drugs Market Size (2021–2032)
10.2 Middle East & Africa Infertility Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Infertility Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa Infertility Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Infertility Drugs Introduction
11.1.4 Merck Revenue in Infertility Drugs Business (2021–2026)
11.1.5 Merck Recent Development
11.2 Ferring
11.2.1 Ferring Company Details
11.2.2 Ferring Business Overview
11.2.3 Ferring Infertility Drugs Introduction
11.2.4 Ferring Revenue in Infertility Drugs Business (2021–2026)
11.2.5 Ferring Recent Development
11.3 MSD
11.3.1 MSD Company Details
11.3.2 MSD Business Overview
11.3.3 MSD Infertility Drugs Introduction
11.3.4 MSD Revenue in Infertility Drugs Business (2021–2026)
11.3.5 MSD Recent Development
11.4 LIVZON
11.4.1 LIVZON Company Details
11.4.2 LIVZON Business Overview
11.4.3 LIVZON Infertility Drugs Introduction
11.4.4 LIVZON Revenue in Infertility Drugs Business (2021–2026)
11.4.5 LIVZON Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Infertility Drugs Introduction
11.5.4 Abbott Revenue in Infertility Drugs Business (2021–2026)
11.5.5 Abbott Recent Development
11.6 Bayer Zydus Pharma
11.6.1 Bayer Zydus Pharma Company Details
11.6.2 Bayer Zydus Pharma Business Overview
11.6.3 Bayer Zydus Pharma Infertility Drugs Introduction
11.6.4 Bayer Zydus Pharma Revenue in Infertility Drugs Business (2021–2026)
11.6.5 Bayer Zydus Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Infertility Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Gonadotropins
Table 3. Key Players of Anti-Estrogens
Table 4. Key Players of Other
Table 5. Global Infertility Drugs Market Size Growth Rate by Indication (US$ Million): 2021 vs 2025 vs 2032
Table 6. Key Players of Ovulatory Dysfunction
Table 7. Key Players of Luteal Phase Deficiency
Table 8. Key Players of Other
Table 9. Global Infertility Drugs Market Size Growth Rate by Route of Administration (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Oral Formulations
Table 11. Key Players of Injectable Formulations
Table 12. Key Players of Vaginal or Transdermal Form
Table 13. Global Infertility Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global Infertility Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 15. Global Infertility Drugs Market Size by Region (US$ Million), 2021–2026
Table 16. Global Infertility Drugs Market Share by Region (2021–2026)
Table 17. Global Infertility Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
Table 18. Global Infertility Drugs Market Share by Region (2027–2032)
Table 19. Infertility Drugs Market Trends
Table 20. Infertility Drugs Market Drivers
Table 21. Infertility Drugs Market Challenges
Table 22. Infertility Drugs Market Restraints
Table 23. Global Infertility Drugs Revenue by Players (US$ Million), 2021–2026
Table 24. Global Infertility Drugs Market Share by Players (2021–2026)
Table 25. Global Top Infertility Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Infertility Drugs Revenue, 2025
Table 26. Ranking of Global Top Infertility Drugs Companies by Revenue (US$ Million) in 2025
Table 27. Global 5 Largest Players Market Share by Infertility Drugs Revenue (CR5 and HHI), 2021–2026
Table 28. Global Key Players of Infertility Drugs, Headquarters and Area Served
Table 29. Global Key Players of Infertility Drugs, Products and Applications
Table 30. Global Key Players of Infertility Drugs, Date of General Availability (GA)
Table 31. Mergers and Acquisitions, Expansion Plans
Table 32. Global Infertility Drugs Market Size by Type (US$ Million), 2021–2026
Table 33. Global Infertility Drugs Revenue Market Share by Type (2021–2026)
Table 34. Global Infertility Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
Table 35. Global Infertility Drugs Revenue Market Share by Type (2027–2032)
Table 36. Global Infertility Drugs Market Size by Application (US$ Million), 2021–2026
Table 37. Global Infertility Drugs Revenue Market Share by Application (2021–2026)
Table 38. Global Infertility Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
Table 39. Global Infertility Drugs Revenue Market Share by Application (2027–2032)
Table 40. North America Infertility Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. North America Infertility Drugs Market Size by Country (US$ Million), 2021–2026
Table 42. North America Infertility Drugs Market Size by Country (US$ Million), 2027–2032
Table 43. Europe Infertility Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Europe Infertility Drugs Market Size by Country (US$ Million), 2021–2026
Table 45. Europe Infertility Drugs Market Size by Country (US$ Million), 2027–2032
Table 46. Asia-Pacific Infertility Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 47. Asia-Pacific Infertility Drugs Market Size by Region (US$ Million), 2021–2026
Table 48. Asia-Pacific Infertility Drugs Market Size by Region (US$ Million), 2027–2032
Table 49. Latin America Infertility Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 50. Latin America Infertility Drugs Market Size by Country (US$ Million), 2021–2026
Table 51. Latin America Infertility Drugs Market Size by Country (US$ Million), 2027–2032
Table 52. Middle East & Africa Infertility Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 53. Middle East & Africa Infertility Drugs Market Size by Country (US$ Million), 2021–2026
Table 54. Middle East & Africa Infertility Drugs Market Size by Country (US$ Million), 2027–2032
Table 55. Merck Company Details
Table 56. Merck Business Overview
Table 57. Merck Infertility Drugs Product
Table 58. Merck Revenue in Infertility Drugs Business (US$ Million), 2021–2026
Table 59. Merck Recent Development
Table 60. Ferring Company Details
Table 61. Ferring Business Overview
Table 62. Ferring Infertility Drugs Product
Table 63. Ferring Revenue in Infertility Drugs Business (US$ Million), 2021–2026
Table 64. Ferring Recent Development
Table 65. MSD Company Details
Table 66. MSD Business Overview
Table 67. MSD Infertility Drugs Product
Table 68. MSD Revenue in Infertility Drugs Business (US$ Million), 2021–2026
Table 69. MSD Recent Development
Table 70. LIVZON Company Details
Table 71. LIVZON Business Overview
Table 72. LIVZON Infertility Drugs Product
Table 73. LIVZON Revenue in Infertility Drugs Business (US$ Million), 2021–2026
Table 74. LIVZON Recent Development
Table 75. Abbott Company Details
Table 76. Abbott Business Overview
Table 77. Abbott Infertility Drugs Product
Table 78. Abbott Revenue in Infertility Drugs Business (US$ Million), 2021–2026
Table 79. Abbott Recent Development
Table 80. Bayer Zydus Pharma Company Details
Table 81. Bayer Zydus Pharma Business Overview
Table 82. Bayer Zydus Pharma Infertility Drugs Product
Table 83. Bayer Zydus Pharma Revenue in Infertility Drugs Business (US$ Million), 2021–2026
Table 84. Bayer Zydus Pharma Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Authors List of This Report
List of Figures
Figure 1. Infertility Drugs Picture
Figure 2. Global Infertility Drugs Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Infertility Drugs Market Share by Type: 2025 vs 2032
Figure 4. Gonadotropins Features
Figure 5. Anti-Estrogens Features
Figure 6. Other Features
Figure 7. Global Infertility Drugs Market Size Comparison by Indication (US$ Million), 2021–2032
Figure 8. Ovulatory Dysfunction Features
Figure 9. Luteal Phase Deficiency Features
Figure 10. Other Features
Figure 11. Global Infertility Drugs Market Size Comparison by Route of Administration (US$ Million), 2021–2032
Figure 12. Oral Formulations Features
Figure 13. Injectable Formulations Features
Figure 14. Vaginal or Transdermal Form Features
Figure 15. Global Infertility Drugs Market Size by Application (US$ Million), 2021–2032
Figure 16. Global Infertility Drugs Market Share by Application: 2025 vs 2032
Figure 17. Hospitals Case Studies
Figure 18. Retail Pharmacy Case Studies
Figure 19. Other Case Studies
Figure 20. Infertility Drugs Report Years Considered
Figure 21. Global Infertility Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 22. Global Infertility Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Infertility Drugs Market Share by Region: 2025 vs 2032
Figure 24. Global Infertility Drugs Market Share by Players in 2025
Figure 25. Global Infertility Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. The Top 10 and 5 Players Market Share by Infertility Drugs Revenue in 2025
Figure 27. North America Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. North America Infertility Drugs Market Share by Country (2021–2032)
Figure 29. United States Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Canada Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Europe Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Europe Infertility Drugs Market Share by Country (2021–2032)
Figure 33. Germany Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. France Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. U.K. Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Italy Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Russia Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Ireland Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Asia-Pacific Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Asia-Pacific Infertility Drugs Market Share by Region (2021–2032)
Figure 41. China Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Japan Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. South Korea Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Southeast Asia Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. India Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Australia & New Zealand Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Latin America Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Latin America Infertility Drugs Market Share by Country (2021–2032)
Figure 49. Mexico Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Brazil Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Middle East & Africa Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Middle East & Africa Infertility Drugs Market Share by Country (2021–2032)
Figure 53. Israel Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Saudi Arabia Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. UAE Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Merck Revenue Growth Rate in Infertility Drugs Business (2021–2026)
Figure 57. Ferring Revenue Growth Rate in Infertility Drugs Business (2021–2026)
Figure 58. MSD Revenue Growth Rate in Infertility Drugs Business (2021–2026)
Figure 59. LIVZON Revenue Growth Rate in Infertility Drugs Business (2021–2026)
Figure 60. Abbott Revenue Growth Rate in Infertility Drugs Business (2021–2026)
Figure 61. Bayer Zydus Pharma Revenue Growth Rate in Infertility Drugs Business (2021–2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Infertility Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Gonadotropins
Table 3. Key Players of Anti-Estrogens
Table 4. Key Players of Other
Table 5. Global Infertility Drugs Market Size Growth Rate by Indication (US$ Million): 2021 vs 2025 vs 2032
Table 6. Key Players of Ovulatory Dysfunction
Table 7. Key Players of Luteal Phase Deficiency
Table 8. Key Players of Other
Table 9. Global Infertility Drugs Market Size Growth Rate by Route of Administration (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Oral Formulations
Table 11. Key Players of Injectable Formulations
Table 12. Key Players of Vaginal or Transdermal Form
Table 13. Global Infertility Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global Infertility Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 15. Global Infertility Drugs Market Size by Region (US$ Million), 2021–2026
Table 16. Global Infertility Drugs Market Share by Region (2021–2026)
Table 17. Global Infertility Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
Table 18. Global Infertility Drugs Market Share by Region (2027–2032)
Table 19. Infertility Drugs Market Trends
Table 20. Infertility Drugs Market Drivers
Table 21. Infertility Drugs Market Challenges
Table 22. Infertility Drugs Market Restraints
Table 23. Global Infertility Drugs Revenue by Players (US$ Million), 2021–2026
Table 24. Global Infertility Drugs Market Share by Players (2021–2026)
Table 25. Global Top Infertility Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Infertility Drugs Revenue, 2025
Table 26. Ranking of Global Top Infertility Drugs Companies by Revenue (US$ Million) in 2025
Table 27. Global 5 Largest Players Market Share by Infertility Drugs Revenue (CR5 and HHI), 2021–2026
Table 28. Global Key Players of Infertility Drugs, Headquarters and Area Served
Table 29. Global Key Players of Infertility Drugs, Products and Applications
Table 30. Global Key Players of Infertility Drugs, Date of General Availability (GA)
Table 31. Mergers and Acquisitions, Expansion Plans
Table 32. Global Infertility Drugs Market Size by Type (US$ Million), 2021–2026
Table 33. Global Infertility Drugs Revenue Market Share by Type (2021–2026)
Table 34. Global Infertility Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
Table 35. Global Infertility Drugs Revenue Market Share by Type (2027–2032)
Table 36. Global Infertility Drugs Market Size by Application (US$ Million), 2021–2026
Table 37. Global Infertility Drugs Revenue Market Share by Application (2021–2026)
Table 38. Global Infertility Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
Table 39. Global Infertility Drugs Revenue Market Share by Application (2027–2032)
Table 40. North America Infertility Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. North America Infertility Drugs Market Size by Country (US$ Million), 2021–2026
Table 42. North America Infertility Drugs Market Size by Country (US$ Million), 2027–2032
Table 43. Europe Infertility Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Europe Infertility Drugs Market Size by Country (US$ Million), 2021–2026
Table 45. Europe Infertility Drugs Market Size by Country (US$ Million), 2027–2032
Table 46. Asia-Pacific Infertility Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 47. Asia-Pacific Infertility Drugs Market Size by Region (US$ Million), 2021–2026
Table 48. Asia-Pacific Infertility Drugs Market Size by Region (US$ Million), 2027–2032
Table 49. Latin America Infertility Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 50. Latin America Infertility Drugs Market Size by Country (US$ Million), 2021–2026
Table 51. Latin America Infertility Drugs Market Size by Country (US$ Million), 2027–2032
Table 52. Middle East & Africa Infertility Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 53. Middle East & Africa Infertility Drugs Market Size by Country (US$ Million), 2021–2026
Table 54. Middle East & Africa Infertility Drugs Market Size by Country (US$ Million), 2027–2032
Table 55. Merck Company Details
Table 56. Merck Business Overview
Table 57. Merck Infertility Drugs Product
Table 58. Merck Revenue in Infertility Drugs Business (US$ Million), 2021–2026
Table 59. Merck Recent Development
Table 60. Ferring Company Details
Table 61. Ferring Business Overview
Table 62. Ferring Infertility Drugs Product
Table 63. Ferring Revenue in Infertility Drugs Business (US$ Million), 2021–2026
Table 64. Ferring Recent Development
Table 65. MSD Company Details
Table 66. MSD Business Overview
Table 67. MSD Infertility Drugs Product
Table 68. MSD Revenue in Infertility Drugs Business (US$ Million), 2021–2026
Table 69. MSD Recent Development
Table 70. LIVZON Company Details
Table 71. LIVZON Business Overview
Table 72. LIVZON Infertility Drugs Product
Table 73. LIVZON Revenue in Infertility Drugs Business (US$ Million), 2021–2026
Table 74. LIVZON Recent Development
Table 75. Abbott Company Details
Table 76. Abbott Business Overview
Table 77. Abbott Infertility Drugs Product
Table 78. Abbott Revenue in Infertility Drugs Business (US$ Million), 2021–2026
Table 79. Abbott Recent Development
Table 80. Bayer Zydus Pharma Company Details
Table 81. Bayer Zydus Pharma Business Overview
Table 82. Bayer Zydus Pharma Infertility Drugs Product
Table 83. Bayer Zydus Pharma Revenue in Infertility Drugs Business (US$ Million), 2021–2026
Table 84. Bayer Zydus Pharma Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Authors List of This Report
List of Figures
Figure 1. Infertility Drugs Picture
Figure 2. Global Infertility Drugs Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Infertility Drugs Market Share by Type: 2025 vs 2032
Figure 4. Gonadotropins Features
Figure 5. Anti-Estrogens Features
Figure 6. Other Features
Figure 7. Global Infertility Drugs Market Size Comparison by Indication (US$ Million), 2021–2032
Figure 8. Ovulatory Dysfunction Features
Figure 9. Luteal Phase Deficiency Features
Figure 10. Other Features
Figure 11. Global Infertility Drugs Market Size Comparison by Route of Administration (US$ Million), 2021–2032
Figure 12. Oral Formulations Features
Figure 13. Injectable Formulations Features
Figure 14. Vaginal or Transdermal Form Features
Figure 15. Global Infertility Drugs Market Size by Application (US$ Million), 2021–2032
Figure 16. Global Infertility Drugs Market Share by Application: 2025 vs 2032
Figure 17. Hospitals Case Studies
Figure 18. Retail Pharmacy Case Studies
Figure 19. Other Case Studies
Figure 20. Infertility Drugs Report Years Considered
Figure 21. Global Infertility Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 22. Global Infertility Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Infertility Drugs Market Share by Region: 2025 vs 2032
Figure 24. Global Infertility Drugs Market Share by Players in 2025
Figure 25. Global Infertility Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. The Top 10 and 5 Players Market Share by Infertility Drugs Revenue in 2025
Figure 27. North America Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. North America Infertility Drugs Market Share by Country (2021–2032)
Figure 29. United States Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Canada Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Europe Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Europe Infertility Drugs Market Share by Country (2021–2032)
Figure 33. Germany Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. France Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. U.K. Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Italy Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Russia Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Ireland Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Asia-Pacific Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Asia-Pacific Infertility Drugs Market Share by Region (2021–2032)
Figure 41. China Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Japan Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. South Korea Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Southeast Asia Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. India Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Australia & New Zealand Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Latin America Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Latin America Infertility Drugs Market Share by Country (2021–2032)
Figure 49. Mexico Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Brazil Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Middle East & Africa Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Middle East & Africa Infertility Drugs Market Share by Country (2021–2032)
Figure 53. Israel Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Saudi Arabia Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. UAE Infertility Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Merck Revenue Growth Rate in Infertility Drugs Business (2021–2026)
Figure 57. Ferring Revenue Growth Rate in Infertility Drugs Business (2021–2026)
Figure 58. MSD Revenue Growth Rate in Infertility Drugs Business (2021–2026)
Figure 59. LIVZON Revenue Growth Rate in Infertility Drugs Business (2021–2026)
Figure 60. Abbott Revenue Growth Rate in Infertility Drugs Business (2021–2026)
Figure 61. Bayer Zydus Pharma Revenue Growth Rate in Infertility Drugs Business (2021–2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232